This article is more than 5 years old. Information may no longer be current.
AcuFocus ACI 7000 simple and effective for presbyopia correction
Click Here to Manage Email Alerts
ROME — The AcuFocus ACI 7000 corneal inlay is a simple, safe method for correcting presbyopia up to 1.5 D, providing enough correction "to make 45- to 60-year-olds happy," said Richard L. Lindstrom, MD, Chief Medical Editor of Ocular Surgery News, at the OSN Rome Symposium.
The ACI 7000 is a small disc with a central hole. The device is placed under a LASIK flap and is designed to increase depth of focus through a "pinhole effect," Dr. Lindstrom said.
Compared with other methods of presbyopia correction, the ACI 7000 has the advantage of being a reversible, minimally traumatic technique that can be carried out under topical anesthesia.
Data from two multicenter studies carried out in Turkey and the European Union demonstrated that emmetropic presbyopic patients implanted with the device retain distance vision and improve both intermediate and near vision. Most patients achieve 20/20 and J1, he said.
A U.S. clinical trial is currently under way and will take approximately 3 years to complete. European regulatory approval is expected in about 1 year, Dr. Lindstrom said.
"Like myopes created the market for PRK and LASIK, presbyopes, who are a huge number, will create a huge market for this device," he said.
The OSN Rome Symposium is a meeting held jointly by Ocular Surgery News, the Italian Association of Cataract and Refractive Surgery and the Italian Society of Ophthalmology.